Literature DB >> 23756164

Kinetics of the CTLA-4 isoforms expression after T-lymphocyte activation and role of the promoter polymorphisms on CTLA-4 gene transcription.

Arianne Pérez-García1, Gemma Osca, Anna Bosch-Vizcaya, Nichollas Kelleher, Nazly Y Santos, Rocío Rodríguez, Yolanda González, Josep M Roncero, Rosa Coll, Maite Serrando, Natàlia Lloveras, Esperanza Tuset, David Gallardo.   

Abstract

Cytotoxic T lymphocyte antigen 4 (CTLA-4) plays a key inhibitory role during T lymphocyte activation. The CTLA4 gene is translated into two proteic isoforms: a full-length protein (flCTLA-4) and a soluble counterpart. We explored the expression of both isoforms on healthy subjects. Whereas in non-stimulated cells the flCTLA-4 isoform is predominant, after stimulation the expression of the soluble form rapidly increases, reaching its maximum 24h after and falling again to the basal levels 72 h after stimulation. In contrast, the flCTLA-4 mRNA levels increase is slower, reaching the maximum level 72 h after stimulation. The presence of the T allele in the promoter positions -1722 and -318 is associated with an increased transcriptional activity and this effect seems to be synergic. We conclude that the kinetics of CTLA-4 isoform expression are sequential, and that the promoter polymorphisms -1722(C/T) and -318(C/T) are involved in the control of the CTLA4 transcription.
Copyright © 2013 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23756164     DOI: 10.1016/j.humimm.2013.05.012

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  9 in total

Review 1.  Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family.

Authors:  Frank A Schildberg; Sarah R Klein; Gordon J Freeman; Arlene H Sharpe
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

2.  PDCD1 and PDCD1LG1 polymorphisms affect the susceptibility to multiple myeloma.

Authors:  Tetsuhiro Kasamatsu; Maaya Awata; Rei Ishihara; Yuki Murakami; Nanami Gotoh; Morio Matsumoto; Morio Sawamura; Akihiko Yokohama; Hiroshi Handa; Norifumi Tsukamoto; Takayuki Saitoh; Hirokazu Murakami
Journal:  Clin Exp Med       Date:  2019-10-16       Impact factor: 3.984

Review 3.  Tipping the balance: inhibitory checkpoints in intestinal homeostasis.

Authors:  Maria E Joosse; Iris Nederlof; Lucy S K Walker; Janneke N Samsom
Journal:  Mucosal Immunol       Date:  2018-11-29       Impact factor: 7.313

4.  Cytotoxic T lymphocyte antigen 4 expression in human breast cancer: implications for prognosis.

Authors:  Haiming Yu; Junlan Yang; Shunchang Jiao; Ying Li; Wei Zhang; Jiandong Wang
Journal:  Cancer Immunol Immunother       Date:  2015-04-17       Impact factor: 6.968

5.  Investigation of soluble and transmembrane CTLA-4 isoforms in serum and microvesicles.

Authors:  Laura Esposito; Kara M D Hunter; Jan Clark; Daniel B Rainbow; Helen Stevens; Jennifer Denesha; Simon Duley; Sarah Dawson; Gillian Coleman; Sarah Nutland; Gwynneth L Bell; Carla Moran; Marcin Pekalski; John A Todd; Linda S Wicker
Journal:  J Immunol       Date:  2014-06-13       Impact factor: 5.422

6.  Cytotoxic T lymphocyte antigen-4 expression in esophageal carcinoma: implications for prognosis.

Authors:  Xiao-Fei Zhang; Ke Pan; De-Sheng Weng; Chang-Long Chen; Qi-Jing Wang; Jing-Jing Zhao; Qiu-Zhong Pan; Qing Liu; Shan-Shan Jiang; Yong-Qiang Li; Hong-Xia Zhang; Jian-Chuan Xia
Journal:  Oncotarget       Date:  2016-05-03

7.  The Influence of Genetic Variations in the CD86 Gene on the Outcome after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Lidia Karabon; Miroslaw Markiewicz; Karolina Chrobot; Monika Dzierzak-Mietla; Edyta Pawlak-Adamska; Anna Partyka; Anna Koclega; Slawomira Kyrcz-Krzemien; Irena Frydecka
Journal:  J Immunol Res       Date:  2018-02-07       Impact factor: 4.818

8.  Genetic association of CTLA4 gene with polycystic ovary syndrome in the Chinese Han population.

Authors:  Jing Su; Yan Li; Guanglong Su; Jing Wang; Ting Qiu; Rong Ma; Lei Zhao
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

Review 9.  Beyond T-Cells: Functional Characterization of CTLA-4 Expression in Immune and Non-Immune Cell Types.

Authors:  Damilola Oyewole-Said; Vanaja Konduri; Jonathan Vazquez-Perez; Scott A Weldon; Jonathan M Levitt; William K Decker
Journal:  Front Immunol       Date:  2020-12-15       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.